Hugo Ten Cate

42.0k total citations · 5 hit papers
568 papers, 21.5k citations indexed

About

Hugo Ten Cate is a scholar working on Hematology, Internal Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Hugo Ten Cate has authored 568 papers receiving a total of 21.5k indexed citations (citations by other indexed papers that have themselves been cited), including 235 papers in Hematology, 214 papers in Internal Medicine and 203 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Hugo Ten Cate's work include Venous Thromboembolism Diagnosis and Management (214 papers), Blood Coagulation and Thrombosis Mechanisms (186 papers) and Atrial Fibrillation Management and Outcomes (99 papers). Hugo Ten Cate is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (214 papers), Blood Coagulation and Thrombosis Mechanisms (186 papers) and Atrial Fibrillation Management and Outcomes (99 papers). Hugo Ten Cate collaborates with scholars based in Netherlands, Germany and United States. Hugo Ten Cate's co-authors include Marcel Levi, Henri M.H. Spronk, Tom van der Poll, Julian Ilcheff Borissoff, Arina J. ten Cate‐Hoek, Harry R. Büller, René van Oerle, Sander J. H. van Deventer, Karly Hamulyák and Paola E. J. van der Meijden and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Hugo Ten Cate

552 papers receiving 20.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Disseminated Intravascular Coagulation

1999 1.4k citations Hugo Ten Cate et al. profile →
Activation of Coagulation after Administration of Tumor Necrosis Factor to Normal Subjects

1990 514 citations Harry R. Büller, Hugo Ten Cate et al. profile →
The Hemostatic System as a Modulator of Atherosclerosis

2011 413 citations Henri M.H. Spronk, Hugo Ten Cate et al. profile →
Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians

2017 254 citations Hugo Ten Cate et al. profile →
Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium

2022 163 citations Jurriën M. ten Berg, Hugo Ten Cate et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hugo Ten Cate Netherlands	76	7.7k	5.6k	5.5k	3.5k	3.3k	568	21.5k
Joost C.M. Meijers Netherlands	67	5.9k 0.8×	3.3k 0.6×	2.9k 0.5×	2.3k 0.7×	2.1k 0.6×	354	16.0k
Nigel S. Key United States	69	9.6k 1.2×	3.2k 0.6×	5.1k 0.9×	1.2k 0.4×	2.3k 0.7×	348	19.3k
Beverley J. Hunt United Kingdom	65	5.7k 0.7×	3.4k 0.6×	4.5k 0.8×	2.0k 0.6×	4.7k 1.4×	340	19.3k
Bernd Jilma Austria	64	4.4k 0.6×	4.8k 0.9×	2.1k 0.4×	2.5k 0.7×	2.4k 0.7×	562	16.7k
Marcel Levi Netherlands	94	9.8k 1.3×	6.6k 1.2×	7.7k 1.4×	9.3k 2.7×	6.6k 2.0×	526	38.8k
Pieter H. Reitsma Netherlands	60	9.0k 1.2×	3.0k 0.5×	4.5k 0.8×	1.5k 0.4×	2.3k 0.7×	248	16.5k
Steffen Maßberg Germany	73	4.6k 0.6×	8.0k 1.4×	2.2k 0.4×	2.5k 0.7×	5.5k 1.7×	447	21.6k
Jerrold H. Levy United States	76	3.4k 0.4×	6.8k 1.2×	4.6k 0.8×	3.0k 0.9×	6.2k 1.9×	472	23.6k
Thomas L. Ortel United States	57	5.3k 0.7×	4.9k 0.9×	5.5k 1.0×	798 0.2×	4.1k 1.2×	277	15.5k
Emmanuel J. Favaloro Australia	58	7.9k 1.0×	3.8k 0.7×	3.5k 0.6×	752 0.2×	3.2k 1.0×	704	15.9k

Countries citing papers authored by Hugo Ten Cate

Since Specialization

Citations

This map shows the geographic impact of Hugo Ten Cate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugo Ten Cate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugo Ten Cate more than expected).

Fields of papers citing papers by Hugo Ten Cate

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugo Ten Cate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugo Ten Cate. The network helps show where Hugo Ten Cate may publish in the future.

Co-authorship network of co-authors of Hugo Ten Cate

This figure shows the co-authorship network connecting the top 25 collaborators of Hugo Ten Cate. A scholar is included among the top collaborators of Hugo Ten Cate based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugo Ten Cate. Hugo Ten Cate is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mariette, Xavier, Sven Borchmann, Sandrine Aspeslagh, et al.. (2025). Major adverse cardiovascular, thromboembolic and malignancy events in the filgotinib rheumatoid arthritis and ulcerative colitis clinical development programmes. RMD Open. 11(1). e005033–e005033. 1 indexed citations

Cate, Vincent ten, Michael Lenz, Andreas Schulz, et al.. (2023). Unsupervised clustering of venous thromboembolism patients by clinical features at presentation identifies novel endotypes that improve prognostic stratification. Thrombosis Research. 227. 71–81. 4 indexed citations

Bor, Willem L., et al.. (2022). Hemostatic biomarkers and antithrombotic strategy in percutaneous left atrial interventions: State-of-the-art review. Thrombosis Research. 215. 41–51. 5 indexed citations

Giesen, Peter L.A., et al.. (2021). Calibrated automated thrombogram II: removing barriers for thrombin generation measurements. Thrombosis Journal. 19(1). 23–60. 9 indexed citations

Witten, Anika, Aaron Isaacs, Elisabetta Castoldi, et al.. (2021). Leukocyte gene expression in post-thrombotic syndrome. Thrombosis Research. 202. 40–42. 1 indexed citations

Brinkman, Herm Jan M., Marjolein Brekelmans, Eva N. Hamulyák, et al.. (2020). Emergencies on direct oral anticoagulants: Management, outcomes, and laboratory effects of prothrombin complex concentrate. Research and Practice in Thrombosis and Haemostasis. 4(4). 569–581. 19 indexed citations

Leader, Avi, Vincent ten Cate, Arina J. ten Cate‐Hoek, et al.. (2020). Anticoagulation in thrombocytopenic patients with hematological malignancy: A multinational clinical vignette-based experiment. European Journal of Internal Medicine. 77. 86–96. 7 indexed citations

Schotten, Ulrich, Sander Verheule, Alexander H. Maass, et al.. (2014). 4246 Hypercoagulability promotes atrial fibrosis and fibrillation. Heart Rhythm. 11(5). 6–7. 1 indexed citations

Grottke, Oliver, Markus Honickel, Joanne van Ryn, et al.. (2014). Dabigatran-induced anticoagulant and bleeding effects can be reversed with both prothrombin complex concentrates and a specific antidote (idarucizumab) in a lethal porcine polytrauma model. European Heart Journal. 35. 4 indexed citations

10.

Konings, Joke, Massimo Cugno, Chiara Suffritti, et al.. (2013). Ongoing Contact Activation in Patients with Hereditary Angioedema. PLoS ONE. 8(8). e74043–e74043. 26 indexed citations

11.

Dieri, Raed Al, Hugo Ten Cate, Patty J. Nelemans, et al.. (2013). Preoperative thrombin generation is predictive for the risk of blood loss after cardiac surgery: a research article. Journal of Cardiothoracic Surgery. 8(1). 154–154. 58 indexed citations

12.

Rennenberg, Roger, Bernard J. van Varik, Leon J. Schurgers, et al.. (2010). Chronic coumarin treatment is associated with increased extracoronary arterial calcification in humans. Blood. 115(24). 5121–5123. 104 indexed citations

13.

Ferreira, Isabel, Henri M.H. Spronk, Bert Bravenboer, et al.. (2010). Body composition as determinant of thrombin generation in plasma. The Hoorn study. Research Online (University of Wollongong). 1 indexed citations

14.

Brüggemann, Lois W., Dirkje W. Sommeijer, Arnaud D. Hauer, et al.. (2007). Hyperglycemia accelerates arterial thrombus formation and attenuates the antithrombotic response to endotoxin in mice. Blood Coagulation & Fibrinolysis. 18(7). 627–636. 10 indexed citations

15.

Slofstra, Sjoukje H., et al.. (2007). Gene Expression Profiling Identifies C/EBPδ as a Candidate Regulator of Endotoxin-induced Disseminated Intravascular Coagulation. American Journal of Respiratory and Critical Care Medicine. 176(6). 602–609. 17 indexed citations

16.

Hoek, J A, Michael T. Nurmohamed, Renaud Marti, et al.. (1992). Prevention of Deep Vein Thrombosis following Total Hip Replacement by Low Molecular Weight Heparinoid. Thrombosis and Haemostasis. 67(1). 28–32. 93 indexed citations

17.

Cate, Hugo Ten, et al.. (1991). Partial in vivo neutralisation of plasma anticoagulant effects of lomoparanR (Org 10172) by protamine chloride. Thrombosis Research. 63(1). 157–167. 6 indexed citations

18.

Cate, Hugo Ten, Ch. P. Henny, Jan W. ten Cate, Harry R. Büller, & N.F. Dabhoiwala. (1987). Randomized Double-Blind, Placebo Controlled Safety Study of a Low Molecular Weight Heparinoid in Patients Undergoing Transurethral Resection of the Prostate. Thrombosis and Haemostasis. 57(1). 92–96. 21 indexed citations

19.

Henny, Ch. P., Hugo Ten Cate, J W ten Cate, et al.. (1986). Thrombosis Prophylaxis in an AT III Deficient Pregnant Woman: Application of a Low Molecular Weight Heparinoid. Thrombosis and Haemostasis. 55(2). 301–301. 32 indexed citations

20.

Henny, Ch. P., H van Bronswijk, Hugo Ten Cate, et al.. (1983). USE OF A NEW HEPARINOID AS ANTICOAGULANT DURING ACUTE HAEMODIALYSIS OF PATIENTS WITH BLEEDING COMPLICATIONS. The Lancet. 321(8330). 890–893. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact